Operations across two segments: the Medical Business Division and the Tape Business Division

「From the current interim consolidated accounting period, the Company established the Business Strategy Headquarters to focus the allocation of management resources on growth businesses and review its business strategy framework from an enterprise-wide perspective, and established the following sales headquarters and divisions by distribution channel under it.」

「Because decisions on allocating management resources and performance evaluation are conducted by the Medical Business and Tape Business based on the nature of the products and merchandise handled and the similarity of their markets and manufacturing methods, the group identifies the Medical Business and Tape Business as its business segments and designates them as its reportable segments.」

「The group identifies the Medical Business and Tape Business as its business segments and designates them as its reportable segments.」

「Because the business management structure was changed as the EC business expanded, the Company has reviewed the classifications of the Healthcare, EC, and Office & Home fields from the current consolidated fiscal year.」

「The group identifies the Medical Business and Tape Business as its business segments and designates them as its reportable segments. There has been no change in the reportable segments from the previous consolidated fiscal year.」

「Because decisions on allocating management resources and performance evaluation are conducted by the Medical Business and Tape Business based on the nature of the products and merchandise handled and the similarity of their markets and manufacturing methods, the group identifies the Medical Business and Tape Business as its business segments and designates them as its reportable segments. There has been no change in the reportable segments from the previous consolidated fiscal year.」

「Because decisions on allocating management resources and performance evaluation are conducted by the Medical Business and Tape Business based on the nature of the products and merchandise handled and the similarity of their markets and manufacturing methods, the group identifies the Medical Business and Tape Business as its business segments and designates them as its reportable segments. There has been no change in the reportable segments from the previous consolidated fiscal year.」

「To strengthen customer-focused business activities, from the current consolidated fiscal year the Company abolished the Tape Business Division and Medical Business Division and placed sales operations under the Domestic Business Division and Overseas Business Division. Under the Domestic Business Division, it established the following sales headquarters by distribution channel. Because decisions on allocating management resources and performance evaluation are conducted by the Medical Business and Tape Business based on the nature of the products and merchandise handled and the similarity of their markets and manufacturing methods, the group identifies the Medical Business and Tape Business as its business segments and designates them as its reportable segments. There has been no change in the reportable segments from the previous consolidated fiscal year.」

「As a result, net sales for the Medical Business as a whole, including overseas operations and comprising the Healthcare and Medical Materials fields, were ¥13,499 million, down 12.7% year on year, and operating income was ¥3,033 million, down 24.0%. As a result, net sales for the Tape Business as a whole, including overseas operations and comprising the Office & Home and Industrial Products fields, were ¥17,652 million, down 3.2% year on year, and operating income was ¥1,571 million, up 18.4%.」

「As a result, net sales for the Medical Business as a whole, including overseas operations and comprising the Healthcare and Medical Materials fields, were ¥3,778 million, down 24.5% year on year, and operating income was ¥799 million, down 40.4%. As a result, net sales for the Tape Business as a whole, including overseas operations and comprising the Office & Home and Industrial Products fields, were ¥5,416 million, down 1.1% year on year, and operating income was ¥544 million, up 59.1%.」

「As a result, net sales for the Medical Business as a whole, including overseas operations and comprising the Healthcare and Medical Materials fields, were ¥15,462 million, down 5.5% year on year, and operating income was ¥3,991 million, down 7.4%. As a result, net sales for the Tape Business as a whole, including overseas operations and comprising the Office & Home and Industrial Products fields, were ¥18,233 million, down 5.7% year on year, and operating income was ¥1,327 million, up 27.7%.」

「As a result, total medical business sales, including the overseas business and combining the healthcare and medical materials fields, amounted to ¥10.411 billion, down 3.7% year on year, while operating profit amounted to ¥2.776 billion, down 3.6%.」

「As a result, net sales for the Medical Business as a whole, including overseas operations and comprising the Healthcare and Medical Materials fields, were ¥5,008 million, down 6.6% year on year, and operating income was ¥1,341 million, down 9.7%. As a result, net sales for the Tape Business as a whole, including overseas operations and comprising the Office & Home and Industrial Products fields, were ¥5,478 million, down 8.2% year on year, and operating income was ¥342 million, up 18.3%.」

「As a result, net sales for the Medical Business as a whole, including overseas operations and comprising the Healthcare and Medical Materials fields, were ¥16,364 million, up 3.1% year on year, and operating income was ¥4,312 million, down 14.2%. As a result, net sales for the Tape Business as a whole, including overseas operations and comprising the Office & Home and Industrial Products fields, were ¥19,339 million, up 0.8% year on year, and operating income was ¥1,039 million, down 24.6%.」

「Information on the amounts of sales and profit or loss for each reportable segment」

「Reportable segments Medical Business Tape Business」

「Information on the amounts of sales and profit or loss for each reportable segment」

「Reportable segments Medical Business Tape Business」

「Accordingly, the group comprises product-based segments organized around business divisions, with the Medical Business and Tape Business designated as its 2 reportable segments.」

「As a result, net sales for the Medical Business Division as a whole, comprising the Healthcare and Medical Materials fields, were ¥14,035 million, up 12.9% year on year, and operating income was ¥3,901 million, up 21.6%.」

「As a result, net sales for the Medical Business Division as a whole, comprising the Healthcare and Medical Materials fields, were ¥9,187 million, up 14.0% year on year, and operating income was ¥2,445 million, up 22.0%.」

「Net sales for the Medical Business Division as a whole were ¥4,482 million, while net sales for the Tape Business Division as a whole were ¥5,940 million.」

「Accordingly, the group comprises product-based segments organized around business divisions, with the Medical Business Division and Tape Business Division designated as its 2 reportable segments.」